Gene therapy reduces HIV levels in small trials

September 20, 2011 by Deborah Braconnier report

(Medical Xpress) -- This weekend at the Interscience Conference on Antimicrobial Agents and Chemotherapy in Chicago, Illinois, researchers from two different study groups, one on the east coast and one on the west coast, reported promising results from studies being conducted in gene therapy for the treatment of HIV.

In the last year, HIV patient Timothy Brown appeared to be cured from his HIV after receiving a from a patient who carried a mutated receptor known as CCR5 on the that the uses. These new studies are based on this case and the receptor CCR5.

The two studies included a total of 15 HIV-infected patients. The researcher removed T cells from the blood of the and modified them with an enzyme engineered by Sangamo BioSciences in California. This enzyme disables the CCR5 receptor. The patients were then infused with 10 billion modified cells.

The patients in the study were originally taking antiretroviral therapy when the study began. Within four weeks, six of the participants stopped taking their medication for a 12 week period. During this time, three of the patients saw a decrease in and one of the patient’s viral loads dropped to an undetectable level. This patient had an advantage at the beginning however. When it comes to genes, each person has two copies, one from the mother and one from the father. This patient already had one copied that carried a naturally occurring mutation. It is estimated that as many as five to 10 percent of HIV patients have a genetic form of this receptor already.

With an estimated 33 million people worldwide diagnosed with HIV, the hope of this research is to create what they call a “functional cure” for AIDS and reduce the need for antiretroviral therapy. More studies are needed to determine the level of gene modification that would provide a complete decrease in the HIV viral load. The goal is patients would still carry the virus but no longer need drugs to control it and prevent disease.

Explore further: Selenium supplements may contribute to reduced HIV viral load

Related Stories

Selenium supplements may contribute to reduced HIV viral load

January 22, 2007

Taking daily selenium supplements appears to increase the level of the essential mineral in the blood and may suppress the progression of viral load in patients with HIV infection, according to an article in the January 22 ...

FDA approves antiretroviral drug

August 7, 2007

The U.S. Food and Drug Administration has approved the antiretroviral drug maraviroc for use in adult human immunodeficiency virus patients.

HIV patients with lymphoma given new hope

June 18, 2010

( -- The Human Immunodeficiency Virus (HIV) is widely treated using highly active antiretroviral therapy (HAART), which patients must continue throughout their lives. Now a new study suggests the patients’ own ...

Spanish doctors unveil promising AIDS vaccine

February 1, 2011

Spanish researchers announced Tuesday they have developed an AIDS vaccine which cuts the viral load by a significant amount in most patients although they cautioned it is still not enough as a treatment.

Recommended for you

Mutational tug of war over HIV's disease-inducing potential

August 23, 2016

A study from Emory AIDS researchers shows how the expected disease severity when someone is newly infected by HIV reflects a balance between the virus' invisibility to the host's immune system and its ability to reproduce.

Dormant copies of HIV mostly defective, new study shows

August 8, 2016

After fully sequencing the latent HIV "provirus" genomes from 19 people being treated for HIV, scientists at Johns Hopkins Medicine report that even in patients who start treatment very early, the only widely available method ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.